Count | |
| 16 | |
| 4 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
Phenytoin/administration & dosage/adverse effects/*pharmacology | 3 |
Phenytoin/*administration & dosage/*adverse effects/blood/therapeutic use | 1 |
| 5 | |
| 10 | |
| 9 | |
| 14 | |
| 4 | |
| 2 | |
| 4 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 4 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
Phenytoin/*administration & dosage/pharmacokinetics/therapeutic use | 1 |
Phenytoin/administration & dosage/*analogs & derivatives/pharmacokinetics | 1 |
Phenytoin/*analogs & derivatives/blood/*pharmacokinetics/urine | 1 |
Phenytoin/administration & dosage/analogs & derivatives/chemistry/*urine | 1 |
Arginine/adverse effects/*analogs & derivatives/blood/*drug effects | 1 |
Phosphoproteins/adverse effects/*antagonists & inhibitors/drug effects | 1 |
C-Reactive Protein/adverse effects/*drug effects/*metabolism | 1 |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 5 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 6 | |
| 1 | |
| 14 | |
| 3 | |
| 3 | |
| 2 | |
| 3 | |
| 4 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 3 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 4 | |
| 1 | |
| 6 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |